Oesophageal Squamous Cell Carcinoma
Showing 26 - 50 of >10,000
Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable Trial in Guangzhou (Cetuximab, Zimberelimab, Docetaxel)
Not yet recruiting
- Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable
- Cetuximab
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University
Oct 24, 2023
Esophageal Squamous Cell Carcinoma, Esophagectomy, Radiotherapy Trial (Since the data were collected retrospectively, there were
Completed
- Esophageal Squamous Cell Carcinoma
- +3 more
- Since the data were collected retrospectively, there were no interventions
- (no location specified)
Oct 31, 2022
Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma
Recruiting
- Esophageal Squamous Cell Carcinoma
-
Shijiazhuang, Hebei, ChinaDepartment of Thoracic Surgery, Fourth Hospital of Hebei Medical
Oct 25, 2023
Esophageal Squamous Cell Carcinoma Trial in Shanghai (Sintilimab, Chemotherapy)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 30, 2023
Carcinoma, Squamous Cell, Oesophageal Cancer Trial in Amsterdam (External beam radiotherapy, Bintrafusp alfa, Paclitaxel)
Recruiting
- Carcinoma, Squamous Cell
- Oesophageal Cancer
- External beam radiotherapy
- +3 more
-
Amsterdam, NetherlandsAcademic Medical Center, Medical Oncology
Jan 15, 2021
Squamous Cell Carcinoma of the Skin Trial in Zhengzhou (Carrilizumab with albumin-binding paclitaxel)
Not yet recruiting
- Squamous Cell Carcinoma of the Skin
- Carrilizumab with albumin-binding paclitaxel
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
May 23, 2023
Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
- Radiotherapy
- Toripalimab
- (no location specified)
Mar 17, 2023
Esophageal Squamous Cell Carcinoma Trial in Beijing (Pembrolizumab, Sinoporphyrin Sodium, Photodynamic therapy)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma
- Pembrolizumab
- +2 more
-
Beijing, Beijing, ChinaBeijing Cancer Hospital & Institute
Nov 23, 2022
Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Toripalimab)
Not yet recruiting
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- (no location specified)
Mar 20, 2023
Head and Neck Squamous Cell Carcinoma Trial (Carrilizumab, bevacizumab,capecitabine)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Carrilizumab, bevacizumab,capecitabine
- (no location specified)
Jul 20, 2023
Cutaneous Squamous Cell Carcinoma Trial (INCB099280)
Not yet recruiting
- Cutaneous Squamous Cell Carcinoma
- (no location specified)
May 24, 2023
The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC Trial in Hanzhou (Cadonilimab Combined Albumin-paclitaxel,
Recruiting
- The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC
- Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil
-
Hanzhou, Zhejiang, ChinaLulu Liu
Jul 14, 2023
Head and Neck Squamous Cell Carcinoma, PET/CT Trial (Neck dissection)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- PET/CT
- Neck dissection
- (no location specified)
Jan 31, 2023
Advanced Esophageal Squamous Carcinoma With Oligometastases Trial (simultaneous with radiotherapy, synchronous with
Not yet recruiting
- Advanced Esophageal Squamous Carcinoma With Oligometastases
- simultaneous with radiotherapy
- synchronous with radiotherapy
- (no location specified)
Nov 16, 2023
Oral Squamous Cell Carcinoma, Oral Mucositis Trial in Guangzhou (Alfacalcidol Oral Solution, Placebo)
Recruiting
- Oral Squamous Cell Carcinoma
- Oral Mucositis
- Alfacalcidol Oral Solution
- Placebo
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital
Aug 24, 2023
Head and Neck Squamous Cell Carcinoma, Radiotherapy, Radiosensitizer Trial in China (Pirfenidone, Placebo)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- +3 more
- Pirfenidone
- Placebo
-
Guangzhou, Guangdong, China
- +4 more
Nov 16, 2023
Esophageal Squamous Cell Carcinoma Trial (Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma
- Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin
- (no location specified)
Aug 17, 2023
Head and Neck Squamous Cell Carcinoma, Locally Advanced Operable Trial in Guangzhou (Cadonilimab, Docetaxel, Cisplatin)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Locally Advanced Operable
- Cadonilimab
- +2 more
-
Guangzhou, Guangdong, China
- +1 more
Sep 4, 2023
Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma
Recruiting
- Head and Neck Squamous Cell Carcinoma
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital, School of Medicine, Zhejiang Univers
Aug 22, 2023
Minimal Residual Disease, Esophageal Squamous Cell Carcinoma Trial in Guangzhou
Not yet recruiting
- Minimal Residual Disease
- Esophageal Squamous Cell Carcinoma
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Jun 10, 2023
Tumors, Carcinoma, Squamous, Antineoplastic Agents Trial (Nivolumab Injection [Opdivo])
Not yet recruiting
- Neoplasms
- +2 more
- Nivolumab Injection [Opdivo]
- (no location specified)
Jul 19, 2023
Esophageal Squamous Cell Carcinoma Stage II, Esophageal Squamous Cell Carcinoma Stage III Trial in Shanghai (Neoadjuvant
Recruiting
- Esophageal Squamous Cell Carcinoma Stage II
- Esophageal Squamous Cell Carcinoma Stage III
- Neoadjuvant Chemoradiotherapy
- +2 more
-
Shanghai, ChinaShanghai Zhongshan Hospital
Jun 26, 2022
Squamous Cell Carcinoma of Oral Cavity, Pharynx Carcinoma, Larynx Carcinoma Trial in Gliwice (Chemotherapy
Recruiting
- Squamous Cell Carcinoma of Oral Cavity
- +3 more
- Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy
-
Gliwice, Silesia, PolandThe Maria Sklodowska-Curie National Research Institute of Oncolo
Aug 7, 2023
People Living With HIV, Oral and Oropharyngeal Cancer, and
Not yet recruiting
- HIV Infections
- +2 more
- Group Meeting (Focus Group)
- Questionnaires
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 20, 2023
Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Tumors Trial in Melbourne
Not yet recruiting
- Cutaneous Squamous Cell Carcinoma
- +3 more
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
May 17, 2023